dihydrotetrabenazine has been researched along with Pancreatic Neoplasms in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barajas, M; Collantes, M; Ecay, M; Escalada, J; Martí-Climent, JM; Peñuelas, I; Quincoces, G; Ramos-Membrive, R; Rodríguez, S | 1 |
1 other study(ies) available for dihydrotetrabenazine and Pancreatic Neoplasms
Article | Year |
---|---|
Lessons from 11C-dihydrotetrabenazine imaging in a xenograft mouse model of rat insulinoma: is PET imaging of pancreatic beta cell mass feasible?
Topics: Animals; Carbon Radioisotopes; Cell Line, Tumor; Fluorodeoxyglucose F18; Heterografts; Insulinoma; Male; Mice; Mice, Inbred BALB C; Pancreatic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Rats; Rats, Wistar; Tetrabenazine; Vesicular Monoamine Transport Proteins | 2017 |